Roscovitine (CYC202)

For research use only.

Catalog No.S1153 Synonyms: Seliciclib, R-roscovitine

98 publications

Roscovitine (CYC202) Chemical Structure

CAS No. 186692-46-6

Roscovitine (CYC202, Seliciclib, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.

Selleck's Roscovitine (CYC202) has been cited by 98 publications

Purity & Quality Control

Choose Selective CDK Inhibitors

Biological Activity

Description Roscovitine (CYC202, Seliciclib, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.
Targets
CDK5/p35 [1]
(Cell-free assay)
Cdc2/CyclinB [1]
(Cell-free assay)
CDK2/CyclinA [1]
(Cell-free assay)
CDK2/CyclinE [1]
(Cell-free assay)
ERK2 [1]
(Cell-free assay)
0.16 μM 0.65 μM 0.7 μM 0.7 μM 14 μM
In vitro

Roscovitine displays high efficiency and high selectivity towards some cyclin-dependent kinases with IC50 of 0.65, 0.7, 0.7 and 0.16 μM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E and cdk5/p53, respectively. [1] Roscovitine reversibly inhibits the prophaselmetaphase transition in the micromolar range of starfish oocytes and sea urchin embryos, inhibits in vitro M-phase-promoting factor activity and in vitro DNA synthesis in Xenopus egg extracts, and suppresses the proliferation of mammalian cell lines with an average IC50 of 16 μM. [1] In mesangial cells, Roscovitine results in a dose-dependent reduction of CDK2 activity that at concentrations of 7.5, 12.5 and 25 mM, Roscovitine causes a 25, 50% and 100% decrease in CDK2 activity, respectively. [2] A recent study shows that Roscovitine inhibits cdk5 kinase activity, cell proliferation, multicellular development, and cdk5 nuclear translocation in Dictyostelium discoideum, without affecting the expression of cdk5 protein during axenic growth. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
LB771-HNC M1HwfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fIUGlEPTB;NEiuPVIyOiEQvF2= NWrRWGU6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
LB2241-RCC MkHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3zDSmlEPTB;NEiuOlIxOiEQvF2= M4LER|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
DU-4475 NF;TOFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2r3[WlEPTB;NEiuOFk{PyEQvF2= MmDzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
LB2518-MEL M3TrRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXoTWM2OD12Nz6wOFQ5KM7:TR?= MofoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H209 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXPXSHp[UUN3ME20Ok4xOTF3IN88US=> MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
CGTH-W-1 NEnN[olIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYDJR|UxRTR2Lkm2PVch|ryP NYjrNFk6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
MS-1 M4jzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MY\JR|UxRTR{Lki5N{DPxE1? NH7RTW09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
GI-ME-N MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIX5WoVKSzVyPUSyMlY3PzFizszN NHfqOIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
DG-75 MoXBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFH1VnBKSzVyPUSyMlY2PDZizszN NEfYXlI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
MLMA MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFKyR|hKSzVyPUSyMlI4QDdizszN MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
HT M1zQcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnvRTWM2OD12Mj6wNFI5KM7:TR?= NIr4Ung9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LC-1F MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPtTWM2OD12MT61O|A2KM7:TR?= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H1882 NEHLdFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXXJR|UxRTRyLkW5PVgh|ryP NIPwVmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NTERA-S-cl-D1 MoLNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{XiU2lEPTB;M{muOVg1OiEQvF2= NU\3eJRDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H345 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV[xUY06UUN3ME2zPE46OTB4IN88US=> NGezeGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
MONO-MAC-6 NGfLNWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mlm0TWM2OD1|OD6yOFc4KM7:TR?= M{Drd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
RS4-11 Mmj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1HJS2lEPTB;M{euO|A3QSEQvF2= NVXZSZhNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
ML-2 NULmWJJCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmDVTWM2OD1|Nz62O|EzKM7:TR?= MoCzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
OPM-2 NGPYbVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHfDbIFKSzVyPUO3MlI6PDlizszN M4TPU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LU-139 NHjjeodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlW5TWM2OD1|Nz6xPFU3KM7:TR?= M{X3b|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
COLO-684 M4XmS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUC5N5NQUUN3ME2zO{4xOTJizszN NULiN|hZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
MOLT-4 NHLUe|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkXSTWM2OD1|Nj6zNlc3KM7:TR?= MmTSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
TE-6 MkHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFnvVHNKSzVyPUO2MlMzPDZizszN NYfrXXM2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TE-441-T Ml;JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIrkToRKSzVyPUO2MlEyPDhizszN NYPqSmI2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
IMR-5 NVvHT|Z1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFzzTY1KSzVyPUO1MlMyOzlizszN NXH5[mVGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
K5 MlnHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYDJR|UxRTN3LkC4OlEh|ryP NUL6TYw3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TE-10 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTN2Lkm0NlIh|ryP M{m4cFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NCI-H2141 M4i4VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX;JR|UxRTN2Lk[1N|Mh|ryP NWDRbHB1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KGN NVTaO|ZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXvHTnNVUUN3ME2zOE4zPTJ2IN88US=> NHqybXM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LP-1 NUnWbms6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXvJR|UxRTN|Lki5NFgh|ryP MmrWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H64 MoP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M17jUWlEPTB;M{OuPFU6PyEQvF2= NVjV[nlGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
RKO MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{PpSGlEPTB;M{OuOVk3QSEQvF2= NXzaN|FSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H526 M4TCeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHzVSVVKSzVyPUOzMlQ6OzZizszN MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
GOTO M{jHVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4jqPWlEPTB;M{KuPVEzQSEQvF2= M3XmbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
Calu-6 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3LBO2lEPTB;M{KuOFc1PSEQvF2= MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LOUCY Moe3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVfJR|UxRTN{LkGyOVMh|ryP M4DVVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
SK-N-FI NG\p[HhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFH6dZdKSzVyPUOxMlc2OzVizszN NILzNYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
SIG-M5 NGm1W2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M33jWWlEPTB;M{GuOlg{OyEQvF2= MmfhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NKM-1 M3zqUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2XpOGlEPTB;M{GuNVM6PyEQvF2= MkGyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-SNU-1 NYjEZXRQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn;KTWM2OD1|MT6xNFU6KM7:TR?= NVe5ZWo2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H82 Mn3pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUO5XnN6UUN3ME2zNU4xOTN3IN88US=> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H510A MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3oTWM2OD1|MD6wN|I6KM7:TR?= M{HiUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ES3 M4PuNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1POXWlEPTB;MkmuPVU5OiEQvF2= M{XabVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
BB30-HNC NFLQRlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTJ7Lkm0PFMh|ryP NXXMTJZCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KM12 NVj4cYI6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYS1Zog6UUN3ME2yPU43OjN7IN88US=> M{nMW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
GI-1 NV;4RVhET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3XJZWlEPTB;MkmuNFEyOyEQvF2= MkDBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NOS-1 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVm5TIwyUUN3ME2yPE46PzN|IN88US=> NVr1ZndNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TE-8 NEDOdFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3TaOmlEPTB;MkiuPVA5KM7:TR?= M1y5[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
TE-9 MmXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmXETWM2OD1{OD63PVY6KM7:TR?= MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
HL-60 M3:0bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW\ZWHZsUUN3ME2yO{46QDZ7IN88US=> NV;OeFNGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
QIMR-WIL M2DsbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NY\ncoxqUUN3ME2yO{46OTR2IN88US=> MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KARPAS-299 MlLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3P2VGlEPTB;Mk[uPFY1PiEQvF2= MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KURAMOCHI M3Ttfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTGcoxKSzVyPUK2MlgxQDJizszN M1fJOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
BL-41 M1ywU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7kTWM2OD1{NT65OVk4KM7:TR?= NXj4[IVvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H2126 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1XGdGlEPTB;MkWuOlUzQSEQvF2= NHzIVXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
HOP-62 Ml70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NI[5b4xKSzVyPUK1MlQ1OjVizszN MnLiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
IST-SL2 MoX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVK3dIZvUUN3ME2yOE42OzR|IN88US=> NXTzelN3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
HH M2m5N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF;leYRKSzVyPUK0MlM5OTlizszN MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LS-513 NWLte3NoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTJ|LkWxO|kh|ryP NInSNlY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
EB-3 MkjiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVHX[pl3UUN3ME2yN{4yQDNzIN88US=> MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
ACN MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3nLO2lEPTB;MkGuN|M5QSEQvF2= NG\EZo09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NOMO-1 Mlv1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjzUHlKSzVyPUKxMlIxODhizszN MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
ES8 MkH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTBTWM2OD1{MT6wOkDPxE1? MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
CESS MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NW\NPXM1UUN3ME2yNE45PTR7IN88US=> NHLSeYs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
BL-70 MmP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUHJR|UxRTJyLkOyO|Qh|ryP M1rYW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MHH-PREB-1 NEnpZWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXrJR|UxRTJyLkCzOVYh|ryP MorPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
BC-1 Mkn2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH3uU|NKSzVyPUG5MlEyQThizszN MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LC4-1 Mo\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo\oTWM2OD1zOD64O|M1KM7:TR?= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
COLO-320-HSR MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGHGXlhKSzVyPUG4Mlc3QDhizszN M3z3TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
A101D NG[0NFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MljpTWM2OD1zOD6zNlA5KM7:TR?= NGXDboM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
BC-3 MlPGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2PxfWlEPTB;MUiuNFMxPSEQvF2= NX21bo1PRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TGW M1nMNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIPnNo5KSzVyPUG3MlgyOjRizszN NFTvWWY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
JAR NGDsOWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUPJR|UxRTF5LkCxOVIh|ryP MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
HD-MY-Z MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4nQcGlEPTB;MU[uPFI1PiEQvF2= NIfqWYs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H1304 M3qyWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTF4LkO2NFEh|ryP NEHEUHU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
OS-RC-2 NWXY[YZST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYrJR|UxRTF3LkizPFIh|ryP NXPOfo9ERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
OCI-AML2 NF;VWpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTF3Lk[0PFIh|ryP MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
HCC1599 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4f6fWlEPTB;MUSuOVk4PSEQvF2= NELScZM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
SCC-3 M3TpS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmTqTWM2OD1zND6yPVU3KM7:TR?= MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
RPMI-6666 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWrJR|UxRTF|LkmxNlEh|ryP M4D6cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MEG-01 MnTPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYrWfZF6UUN3ME2xN{45Ozd7IN88US=> MonUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
Raji MlvrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1LHWWlEPTB;MUOuO|g6PCEQvF2= MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
RPMI-8402 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFHMNmVKSzVyPUGzMlYzPjJizszN MmnEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
GCIY NYjU[IxlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHOd5NKSzVyPUGyMlg3OTNizszN Mk\oQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
697 NH64cmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIG1UW1KSzVyPUGyMlYxODdizszN NF;ofJA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
D-247MG NFzTUVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1\XbWlEPTB;MUKuN|UyPiEQvF2= NGfZdoE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NB1 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEO0U5JKSzVyPUGyMlM{ODhizszN MlGwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
COR-L279 MnzNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYLRbmdUUUN3ME2xNk4zQTB5IN88US=> M3K1NlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LB831-BLC M2LnOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFfib4FKSzVyPUGxMlU3OjRizszN NXf3TpB{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
ST486 NFXWXnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHIW3ZKSzVyPUGwMlM2OSEQvF2= NUj6V3A1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
SK-UT-1 NEnVTZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUW2RmNPUUN3ME2xNE4{PSEQvF2= MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
BB65-RCC NXXNdJFsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmi3TWM2OD17Lkm3OFk2KM7:TR?= Mlu0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
KARPAS-422 NXWyUpBNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWWzXYNtUUN3ME25Mlk3OzN4IN88US=> NGj0bW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
Becker NIC5RlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXXs[VVIUUN3ME25MlQ3ODh{IN88US=> M{nCN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
KS-1 NFjne3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkDETWM2OD17LkS1O|g2KM7:TR?= NFLrT289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
JiyoyeP-2003 M3i0Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3vudmlEPTB;OD61NFI3PCEQvF2= MmnPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCCIT MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH3BcmNKSzVyPUeuOVU1QDJizszN MoftQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
MRK-nu-1 NUHGbHQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmDsTWM2OD15LkGyPVY6KM7:TR?= MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
A3-KAW M1fmZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXrJR|UxRTVwN{[xNVYh|ryP NFr6e2o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
SK-N-MC NYnMWmdbeUiWUzDhd5NigQ>? NYT3Wmk3eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NWnTRYtGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
LP-1 MUjBdI9xfG:|aYOgZZN{[Xl? MVuzNEB2VQ>? MmjON{BpenN? NXzaTIpUUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDMVE0yKGOnbHzzJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KHW|aX7nJHRWVkWOIIP0ZYlvcW6pIHL5JIZtd3diY4n0c41mfHK7 NFHud4w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
LP-1 NGL3NHJEgXSxdH;4bYNqfHliYYPzZZk> NFvWSnAzOCC2bzCzNEB2VQ>? NHKyT3UzPCCqcoO= NYTyNnlsS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVFBvMTDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gc4Yh[2WubDD2bYFjcWyrdImgZZQhOjBidH:gN|AhfU1idILlZZRm\CCob4KgNlQhcHK|IH\vcIxwf2WmIHL5JJdie2ixdYSgcYVie3W{ZXSgZYZ1\XJidH;0ZYwhPzJiaILzJIdzd3e2aDDw[ZJqd2RiYXzhcYFzKGKudXWgZZN{[XlicnXsZZRqfmVidH:gZ49vfHKxbB?= M1v2SVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
LP-1 NGrVPItCeG:ydH;zbZMh[XO|YYm= MkjTN|AhfU1? M1nGW|EvPSCqcoO= MXTJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKEySLUGgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKFKQQTDwc4x6dWW{YYPlJFIheGixc4Doc5NmemmwZTCyJIxmfmWuIHH0JFMxKHWPIHHmeIVzKDFwNTDodpMh[nliaX3teY5w[myxdITpcoc> NFT0XGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
LP-1 MYjBdI9xfG:|aYOgZZN{[Xl? NVv4VHlkOzBidV2= MlK4N{BpenN? MlLXTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCOUD2xJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBw\iCPY3ytNUBxem:2ZXnuJIxmfmWuIHH0JFMxKHWPIHHmeIVzKDNiaILzJIJ6KGmvbYXuc4Jtd3S2aX7n NVntSnRURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
LP-1 MVXBdI9xfG:|aYOgZZN{[Xl? NEjCfFQ{OCC3TR?= Moj2N{B1dyB3IHjydy=> MX\JcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKEySLUGgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hdGW4ZXygc4Yh[2ynYY\l[EBRSVKSIHH0JFMxKHWPIHHmeIVzKDNidH:gOUBpenNiYomgbY1ufW6xYnzveJRqdmd? MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 MWfBdI9xfG:|aYOgZZN{[Xl? MlvtN|AhfU1? NXzVdG9yPSCqcoO= M1jHfmlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gcIV3\Wxib3[gZ4xm[X[nZDDQRXJRKGG2IEOwJJVOKGGodHXyJFUhcHK|IHL5JIludXWwb3Lsc5R1cW6p NXPOSJp[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 NF[2fJdCeG:ydH;zbZMh[XO|YYm= MoDlN|AhfU1? MnnMNU42KGi{cx?= NX:5OHBzUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDmZZN1KHOub4egcYloemG2aX7nJIh6eGW{cHjvd5Bpd3K7bHH0[YQhWk6DIIDvcJlu\XKjc3WgNm8h\m:{bTDheEA{OCC3TTDh[pRmeiBzLkWgbJJ{KGK7IHntcZVvd2Kub4T0bY5o M1zyOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
RPM18226 NV23blI5SXCxcITvd4l{KGG|c3H5 MUizNEB2VQ>? MmO3NU42KGi{cx?= NHv6XppKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIGLQUVE5OjJ4IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDv[kBTVkFicH;sfY1memG|ZTCyJJBpd3OyaH;z[ZJqdmViMjDs[ZZmdCCjdDCzNEB2VSCjZoTldkAyNjViaILzJIJ6KGmvbYXuc4Jtd3S2aX7n M{jBU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
RPM18226 NIHJWG1CeG:ydH;zbZMh[XO|YYm= NXvqW3hXOzBidV2= MYWzJIhzew>? M4XnOWlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iUmDNNVgzOjZiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJG1kdC1zIIDyc5RmcW5ibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgN{BpenNiYomgbY1ufW6xYnzveJRqdmd? MljpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
RPM18226 Mmr1RZBweHSxc3nzJIF{e2G7 MWqzNEB2VQ>? M1frOVMhfG9iNTDodpM> NHLnRnFKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIGLQUVE5OjJ4IHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIxmfmWuIH;mJINt\WG4ZXSgVGFTWCCjdDCzNEB2VSCjZoTldkA{KHSxIEWgbJJ{KGK7IHntcZVvd2Kub4T0bY5o MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 NWrsXGUxSXCxcITvd4l{KGG|c3H5 MljiN|AhfU1? MnjoN{BpenN? NWSxTWNYUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDjbIFv\2W|IHnuJHhKSVBicILveIVqdiCuZY\lcEBifCB|MDD1UUBi\nSncjCzJIhzeyCkeTDpcY12dm:kbH;0eIlv\w>? M2j0TVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 MUTBdI9xfG:|aYOgZZN{[Xl? MVSzNEB2VQ>? MVmzJIhzew>? M3nZcGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiY3jhcodmeyCrbjDzeZJ3cX[rbjDwdo91\WmwIHzleoVtKGG2IEOwJJVOKGGodHXyJFMhcHK|IHL5JIludXWwb3Lsc5R1cW6p MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
RPM18226 NGXXXHZCeG:ydH;zbZMh[XO|YYm= NYKyOHVSOzBidV2= MWCzJIhzew>? M1TxdWlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iUmDNNVgzOjZiY3XscJMh[XRiM{CgeW0h[W[2ZYKgN{BpenNidYPpcochXFWQRVygd5RicW6rbnegZpkh\myxdzDjfZRwdWW2com= MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 NH24Om1CeG:ydH;zbZMh[XO|YYm= MnPCN|AhfU1? NXLN[FRSOS53IHjydy=> NVHYT4doUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gc4YhWk6DIIDvcJlu\XKjc3WgNkBxcG:|cHjvd4VzcW6nIEKgcIV3\WxiYYSgN|AhfU1iYX\0[ZIhOS53IHjyd{BjgSCrbX31co9jdG:2dHnu[y=> M4XDd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 MnnxRZBweHSxc3nzJIF{e2G7 NIrJTYs{OCC3TR?= MWSxMlUhcHK| NUHCSVhoUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDk[ZBpd3OyaH;yfYxifGmxbjDv[kBxWmJiYYSgV|I1QS:WMkWyJIF1KDNyIIXNJIFnfGW{IEGuOUBpenNiYomgbY1ufW6xYnzveJRqdmd? M1e0[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 M3\CSGN6fG:2b4jpZ4l1gSCjc4PhfS=> NULjcWJ3OjBidH:gN|AhfU1? MX2xOkBpenN? MknpR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUmNKNUh7MkmgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKGOnbHygeoli[mmuaYT5JIF1KDJyIITvJFMxKHWPIITy[YF1\WRiZn;yJFE3KGi{czDmc4xtd3enZDDifUB4[XOqb4X0JI1m[XO3cnXkJIFnfGW{IITveIFtKDd{IHjyd{Boem:5dHigdIVzcW:mIHHsZY1ieiCkbIXlJIF{e2G7IILlcIF1cX[nIITvJINwdnS{b3y= NYHmV5g{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 NUn0PY9qSXCxcITvd4l{KGG|c3H5 NIHCVo4{OCC3TR?= M1PBTlMhcHK| MmXuTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gUYNtNTFicILveIVqdiCuZY\lcEBifCB|MDD1UUBi\nSncjCzJIhzeyCkeTDpcY12dm:kbH;0eIlv\w>? NYPjU|NzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 MXjBdI9xfG:|aYOgZZN{[Xl? MX:zNEB2VQ>? M2jQXlMhcHK| NUnPV5pWUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDjbIFv\2W|IHnuJGJkdC1{IIDyc5RmcW5ibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgN{BpenNiYomgbY1ufW6xYnzveJRqdmd? Ml;ZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 NGTFWJNCeG:ydH;zbZMh[XO|YYm= MVWzNEB2VQ>? MlyxN{BpenN? NIfhfIlKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG2IEOwJJVOKGGodHXyJFMhcHK|IIXzbY5oKFSXTlXMJJN1[WmwaX7nJIJ6KG[ub4egZ5l1d22ndIL5 NILZdVY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
NCI-H929 MX;BdI9xfG:|aYOgZZN{[Xl? M3;5clMxKHWP NV3ycmRIOS53IHjydy=> M1fvcGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJHJPSSCyb3z5cYVz[XOnIEKgdIhwe3Cqb4Pldolv\SB3IHzleoVtKGG2IEOwJJVOKGGodHXyJFEvPSCqcoOgZpkhcW2vdX7vZoxwfHSrbne= NED5WXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
NCI-H929 NYPwXpdLSXCxcITvd4l{KGG|c3H5 M2\P[FMxKHWP M4Hxd|EvPSCqcoO= Mln4TY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gTIRuOiCuZY\lcEBifCB|MDD1UUBi\nSncjCxMlUhcHK|IHL5JIludXWwb3Lsc5R1cW6p MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 M4rZbGFxd3C2b4Ppd{Bie3OjeR?= NXLz[nRpOzBidV2= M1S4OVEvPSCqcoO= MnHBTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCxZjDwOVMh[WOldX31cIF1cW:wIHH0JFMxKHWPIHHmeIVzKDFwNTDodpMh[nliaX3teY5w[myxdITpcoc> NGDSXnU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
SK-N-MC MWnxTHRUKGG|c3H5 NVruNZB6eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NHjBZ4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC4NFcxOyd-MkGwPFA4ODN:L3G+
HCT116 NVK3V3ZPTnWwY4Tpc44h[XO|YYm= MlLqN|AhfG9iNECgeY1wdC:O MWCyOEBpenN? NH24UnRKdmirYnn0bY9vKG:oIHP5Z4xqdiCDIHnuJIh2dWGwIFjDWFEyPiClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDwdo91\WmwIHzleoVtKGG2IEOwJJRwKDRyIIXtc4wwVCCjZoTldkAzPCCqcoOgZpkhcW2vdX7vZoxwfHSrbnegZY5idHm|aYO= MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB6MEewN{c,OjFyOEC3NFM9N2F-
HCT116 NFOybHBHfW6ldHnvckBie3OjeR?= MWGzNEB1dyB2MDD1cY9tN0x? NVzCO4ZrOjRiaILz NUPkUHhFUW6qaXLpeIlwdiCxZjDjfYNtcW5iQjDpckBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gdJJwfGWrbjDs[ZZmdCCjdDCzNEB1dyB2MDD1cY9tN0xiYX\0[ZIhOjRiaILzJIJ6KGmvbYXuc4Jtd3S2aX7nJIFv[Wy7c3nz MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB6MEewN{c,OjFyOEC3NFM9N2F-
HCT116 NFXjcZZHfW6ldHnvckBie3OjeR?= M2O2bVMxKHSxIESwJJVud2xxTB?= NWrHWotrOjRiaILz NWHDeFAyUW6qaXLpeIlwdiCxZjDjfYNtcW5iREGgbY4hcHWvYX6gTGNVOTF4IHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJJBzd3SnaX6gcIV3\WxiYYSgN|AhfG9iNECgeY1wdC:OIHHmeIVzKDJ2IHjyd{BjgSCrbX31co9jdG:2dHnu[{BidmGueYPpdy=> NV7Q[4lbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGwPFA4ODNpPkKxNFgxPzB|PD;hQi=>
HCT116 MVTGeY5kfGmxbjDhd5NigQ>? MV[zNEB1dyB2MDD1cY9tN0x? MorNNlQhcHK| NHPlcFVKdmirYnn0bY9vKG:oIFPET|IhcW5iaIXtZY4hUEOWMUG2JINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKHC{b4TlbY4hdGW4ZXygZZQhOzBidH:gOFAhfW2xbD;MJIFnfGW{IEK0JIhzeyCkeTDpcY12dm:kbH;0eIlv\yCjbnHsfZNqew>? MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB6MEewN{c,OjFyOEC3NFM9N2F-
HT-29 Ml7ESpVv[3Srb36gZZN{[Xl? M1GxZVIvPSC2bzC0NEB2VQ>? M4T1VlI1KGi{cx?= M3TMb2lvcGmkaYTpc44hd2ZicnX0bY5w[myjc4TvcYEheHKxdHXpckBqdiCqdX3hckBJXC1{OTDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gc4Yh[3mlbHnuJGEhdGW4ZXygZZQhOi53IITvJFQxKHWPIHHmeIVzKDJ2IHjyd{BjgSCrbX31co9jdG:2dHnu[y=> MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
MCF7 NGrCNYVE\WyuIHP5Z4xmKGG|c3H5 M1TWSVI1KGi{cx?= MknJR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhTzJxTTDwbIF{\SCjZoTldkAzPCCqcoOgeZNqdmdicILvdIllcXWvIHnv[Ill\SCjbnSgRpJlXSC|dHHpcolv\yCkeTDmcI94KGO7dH;t[ZRzgQ>? NYXWNWVjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
RPMI8226 NY\LXmFlS2WubDDjfYNt\SCjc4PhfS=> MmroNlQhcHK| MYrD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDSVG1KQDJ{NjDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiR{KvUUBxcGG|ZTDh[pRmeiB{NDDodpMhfXOrbnegdJJweGmmaYXtJIlw\GmmZTDhcoQhSnKmVTDzeIFqdmmwZzDifUBndG:5IHP5eI9u\XS{eR?= MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
MCF7 Mn;RR4VtdCCleXPs[UBie3OjeR?= M3;mZ|I1KGi{cx?= MUjD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KGSnY4LlZZNmKGmwIGOgdIhie2ViY3XscEBxd3C3bHH0bY9vKGGodHXyJFI1KGi{czD1d4lv\yCycn;wbYRqfW1iaX;kbYRmKGGwZDDCdoRWKHO2YXnubY5oKGK7IH\sc5ch[3m2b33leJJ6 Mn\5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2MUe0NVcoRjJzNEG3OFE4RC:jPh?=
MCF7 NIr6dGpE\WyuIHP5Z4xmKGG|c3H5 M{PwOlI1KGi{cx?= MkfmR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhe3WkLVexJJBp[XOnIHHmeIVzKDJ2IHjyd{B2e2mwZzDwdo9xcWSrdX2gbY9lcWSnIHHu[EBDemSXIIP0ZYlvcW6pIHL5JIZtd3diY4n0c41mfHK7 M37BZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEG3OFE4Lz5{MUSxO|QyPzxxYU6=
RPMI8226 MX3D[YxtKGO7Y3zlJIF{e2G7 MlzrNlQhcHK| MlzmR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gVnBOUTh{Mk[gZ4VtdHNiYYPz[ZN{\WRiYYOgZYNkfW23bHH0bY9vKGG2IIP1Zk1IOSCyaHHz[UBi\nSncjCyOEBpenNidYPpcocheHKxcHnkbZVuKGmxZHnk[UBidmRiQoLkWUB{fGGrbnnu[{BjgSCobH;3JIN6fG:vZYTyfS=> NH3GTnE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
MCF7 NXzkXYdRS2WubDDjfYNt\SCjc4PhfS=> Ml:wPFAhfU1? MmLFNlQhcHK| NGLSeoVE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBOS0Z5IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDv[kBi[3SrdnXsfUBz\XCuaXPheIlv\yCGTlGgcIV3\WxiYYSgPFAhfU1iYX\0[ZIhOjRiaILzJJV{cW6pIIDyc5Bq\Gm3bTDpc4Rq\GViYX7kJGJz\FVic4ThbY5qdmdiYomg[oxwfyCleYTvcYV1enl? MlvrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2MUe0NVcoRjJzNEG3OFE4RC:jPh?=
MCF7 MmTKSpVv[3Srb36gZZN{[Xl? M4W1ZVIxKHWP M3O1SFI1KGi{cx?= MWDJcoR2[3Srb36gc4YheDV|LXTldIVv\GWwdDD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliaX6gbJVu[W5iTVPGO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBw\iCyMkGgW2FHOSCuZY\lcEBifCB{MDD1UUBi\nSncjCyOEBpenNiYomgbY1ufW6xZnz1c5Jme2OnbnPlJIF{e2G7 NWDqWmU{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
RPMI8226 NXXhd3c2S2WubDDjfYNt\SCjc4PhfS=> MXqyOEBpenN? MUfD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDSVG1KQDJ{NjDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBUKHCqYYPlJINmdGxicH;weYxifGmxbjDh[pRmeiB{NDDodpMhfXOrbnegdJJweGmmaYXtJIlw\GmmZTDhcoQhSnKmVTDzeIFqdmmwZzDifUBndG:5IHP5eI9u\XS{eR?= M361TVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEG3OFE4Lz5{MUSxO|QyPzxxYU6=
RPMI8226 MWPD[YxtKGO7Y3zlJIF{e2G7 NH3zWYo5OCC3TR?= NHLQUmMzPCCqcoO= Ml3IR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gVnBOUTh{Mk[gZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKGGldHn2[Yx6KHKncHzpZ4F1cW6pIFTORUBt\X[nbDDheEA5OCC3TTDh[pRmeiB{NDDodpMhfXOrbnegdJJweGmmaYXtJIlw\GmmZTDhcoQhSnKmVTDzeIFqdmmwZzDifUBndG:5IHP5eI9u\XS{eR?= NXrJVG1KRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
A549 M13SUGFxd3C2b4Ppd{Bie3OjeR?= NHLoTXMzKHWP MVq0PEBpenN? MXvJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKEF3NEmgZ4VtdHNiYYPz[ZN{\WRiYYOgSG5CKG[{YXft[Y51[XSrb36gZZQhOiC3TTDh[pRmeiB2ODDodpMh[nliYXfhdo9{\SCpZXyg[Yxm[3S{b4Doc5Jme2m| NFW0Uos9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{[yN|Q6OSd-MkO2NlM1QTF:L3G+
Sf9 NVS4TVZjTnWwY4Tpc44h[XO|YYm= NVnQXIo3OTBibXnudy=> M1XkVGlvcGmkaYTpc44hd2ZiSHnzMVYufGGpZ3XkJJJm[2:vYnnuZY51KGi3bXHuJGNFUzJxY4njcIlvTSCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMucW6oZXP0[YQhe2Z7IHPlcIx{KHW|aX7nJIhqe3SxbnWgTFEh[XNic4Xid5Rz[XSnIHHmeIVzKDFyIH3pcpMh[nlibHnxeYllKHOlaX70bYxt[XSrb36gZ492dnSrbnegbY4heHKnc3XuZ4Uhd2ZiW3fhcY1iNTN{UG3BWHAtKEmFNUCgQUAxNjFizszNMi=> NXX1XmlsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0NVc2PjZpPkK0OFE4PTZ4PD;hQi=>
BJ MWDGeY5kfGmxbjDhd5NigQ>? MmCwNVAhfU1? M2TuOFExKGSjeYO= NF;wWopUfXCycnXzd4lwdiCxZjDz[Y5me2OnbnPlJIlvKGi3bXHuJGJLKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHPlcIwhdnWvYnXyJIF1KDFyIIXNJIFnfGW{IEGwJIRigXNiYomgd4Vv\XOlZX7j[UBz\X[ncoPhcEBie3OjeR?= M{XSelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NkixPVg3Lz5{NE[4NVk5PjxxYU6=
BJ NGi0[GNHfW6ldHnvckBie3OjeR?= NYi2VI9kOTBidV2= MU[xNEBl[Xm| NGfpellKdmirYnn0bY9vKG:oIHH0ZZhq[SC2ZXzhcodq\WO2YYPpZU1ufXSjdHXkJIlvKGi3bXHuJGJLKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHPlcIwhdnWvYnXyJIF1KDFyIIXNJIFnfGW{IEGwJIRigXNiYomgd4Vv\XOlZX7j[UBz\X[ncoPhcEBie3OjeR?= MlXLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4OEG5PFYoRjJ2NkixPVg3RC:jPh?=
MCF7 MVrGeY5kfGmxbjDhd5NigQ>? NXfzUIRjOTBidV2= NYPGPWtJOTBibXnudy=> NV[yNWFOW2Wwc3n0bZpifGmxbjDv[kBqdm[{YYLl[E1qdmS3Y3XkJGRPSSCmYX3h[4UhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4h[2:ub375JIZwem2jdHnvckBifCBzMDD1UUBxemW2cnXheIVlKG[xcjCxNEBucW6|IH\vcIxwf2WmIHL5JIlzemGmaXH0bY9vKG[xcjC0JIhzeyCvZXHzeZJm\CCjZoTldkAyOCCmYYnzJIJ6KGO{eYP0ZYwhfmmxbHX0JJN1[WmwaX7nJIFv[Wy7c3nz NEXtUXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nki1NVUxPSd-Mk[4OVE2ODV:L3G+
Caco2 MW\D[YxtKGO7Y3zlJIF{e2G7 MlzsR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gR4FkdzJiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEdzL2OgdIhie2ViYomgTI9m[2i|dDDzeIFqdmmwZzDiZZNm\CCobIXvdoV{[2WwY3WgZZN{[Xl? NYnSVIc1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyNVQzOzFpPkK4NlE1OjNzPD;hQi=>
HaCaT M1TvRmNmdGxiY4njcIUh[XO|YYm= M2nDO2NmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJGhiS2GWIHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMT;TJJBp[XOnIHL5JGhw\WOqc4Sgd5RicW6rbnegZoF{\WRiZnz1c5Jme2OnbnPlJIF{e2G7 MkDLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{MUSyN|EoRjJ6MkG0NlMyRC:jPh?=
HuH7 NHHtVoJE\WyuIHP5Z4xmKGG|c3H5 NWO2NHpJS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hUHWKNzDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiR{GvV{BxcGG|ZTDifUBJd2WlaIP0JJN1[WmwaX7nJIJie2WmIH\seY9z\XOlZX7j[UBie3OjeR?= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJzNEKzNUc,Ojh{MUSyN|E9N2F-
PC3 NVXDfpRoS2WubDDjfYNt\SCjc4PhfS=> NIDtboFE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBRSzNiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEd{L12gdIhie2ViYomgTI9m[2i|dDDzeIFqdmmwZzDiZZNm\CCobIXvdoV{[2WwY3WgZZN{[Xl? MojJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{MUSyN|EoRjJ6MkG0NlMyRC:jPh?=
MDA-MB-231 NWXoSJNpS2WubDDjfYNt\SCjc4PhfS=> NWC3RZBUS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hVUSDLV3CMVI{OSClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhTzFxUzDwbIF{\SCkeTDIc4VkcHO2IIP0ZYlvcW6pIHLhd4VlKG[udX;y[ZNk\W6lZTDhd5NigQ>? Mnm0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{MUSyN|EoRjJ6MkG0NlMyRC:jPh?=
HCT116 NHT3XoxE\WyuIHP5Z4xmKGG|c3H5 MmOzR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gTGNVOTF4IHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMT;TJJBp[XOnIHL5JGhw\WOqc4Sgd5RicW6rbnegZoF{\WRiZnz1c5Jme2OnbnPlJIF{e2G7 Mn3SQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{MUSyN|EoRjJ6MkG0NlMyRC:jPh?=
SK-N-MC MlXQdWhVWyCjc4PhfS=> NVvRO4U4eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> Mm\sQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3NUe0N|AoRjJ6NUW3OFMxRC:jPh?=
A673 MkTGdWhVWyCjc4PhfS=> NEiyZ|ByUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQU[3N{Bk\Wyucx?= NVLocIh{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
DAOY M2HSRZFJXFNiYYPzZZk> Mkm5dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKESDT2mgZ4VtdHN? MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-37 NYjpS4xLeUiWUzDhd5NigQ>? MVHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvM{egZ4VtdHN? NGqyOZA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SJ-GBM2 Mn\mdWhVWyCjc4PhfS=> MYnxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?= MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
LAN-5 M3rQc5FJXFNiYYPzZZk> NYHsZ2xGeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFzBUk02KGOnbHzz NF3rTFQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-MC NWfudY9OeUiWUzDhd5NigQ>? MULxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= NFHY[4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEG5PVcxOid-M{CxPVk4ODJ:L3G+

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
pT231-tau / pS202-tau / tau; 

PubMed: 30915013     


SH-SY5Y-(P301L) cells were exposed for 6 h to a range of roscovitine concentrations. Cells were harvested and proteins were resolved by SDS-PAGE followed by western blotting.

p-Rb / p-CDK2 / CDK2 / Cyclin D1 / Cyclin A2 / ERα / ERβ/ AIB1 / PELP1 ; 

PubMed: 21834972     


(a) The model cells MCF7, MCF7-TamR, MCF7-HER2, and MCF7-LTLTca were treated with roscovitine and the status of cell cycle regulators and the estrogen receptor (ERα) signaling proteins was analyzed by western blotting. 

30915013 21834972
Immunofluorescence
CDK1 / Smek2 / FUBP1 / Cdc20 ; 

PubMed: 24534090     


A-D Validation of changes in chromatin affinity following Cdk inhibition of indicated candidates (2 h, 50 μM roscovitine) using Triton extraction and immunofluorescence (IF) in HeLa cells. Quantification of IF data was performed by measuring changes in signal intensities in Image J.

E2F1 / FASN / Bmi1 / Cyclin D2 / CDK2 / CDK4 ; 

PubMed: 20890301     


Immunofluorescence analysis of E2F1, FASN, E2F1/Shh target Bmi1, cyclin D2, cdk 2, and cdk 4 in Pzp53med cells treated with DMSO (control) or the cdk inhibitor roscovitine (10 nM) for 18 hours.

24534090 20890301
Growth inhibition assay
Cell viability; 

PubMed: 29996940     


Cell viability assay on OVCAR5, OAW42, SKOV3 and NL3507 cells treated with roscovitine (2, 5, 10, 20, 40 μM) up to 96 h. Each point represents the mean of three replicates. Error bars, SD

29996940
In vivo Roscovitine, at a dose of 50 mg/kg, significantly inhibits growth of The Ewing's sarcoma family of tumors (ESFT) xenografts. [4] Roscovitine enhances the antitumor effect of doxorubicin without increased toxicity with a mechanism that involves cell cycle arrest rather than apoptosis in nude mice bearing established MCF7 xenografts. [5]

Protocol

Kinase Assay:[1]
- Collapse

Enzymes :

Kinases activities are assayed at 30 °C in buffer C. Blank values are subtracted from the data and activities calculated as molar amount of phosphate incorporated in protein acceptor during a 10-minute incubation. Controls are performed with appropriate dilutions of DMSO. In a few cases, phosphorylation of the substrate is assessed by autoradiography after SDS/PAGE. p34cdc2/cyclin B is purified from M-phase starfish (M. glacialis) oocytes by affinity chromatography. It is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP (3000 Ci/mmol; 1 mCi/mL) in a final volume of 30 μL. After a 10-minute incubation at 30 °C, 25-μL aliquots of supernatant are spotted onto pieces of Whatman P81 phosphocellulose paper, and, after 20 seconds, the filters are washed five times (for at least 5 minutes each time) in a solution of 10mL phosphoric acid/L water. The wet filters are transferred into 6-mL plastic scintillation vials, 5 mL ACS scintillation fluid is added and the radioactivity measured in a Packard counter. The kinase activity is expressed as molar amount of phosphate incorporated in histone H1 during a 10-minutes incubation or as a percentage of maximal activity. p33cdk2/cyclin A and p33cdk2/cyclinE are reconstituted from extracts of sf9 insect cells infected with various baculoviruses. Cyclins A and E are fusion proteins with glutathione S-transferase and the complexes are purified on glutathione-agarose beads. Kinase activities are assayed with 1 mg/mL histone H1, in the presence of 15 μM [γ-32P]ATP, during 10 minutes, in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/p35 is purified from bovine brain, excluding the Mono S-chromatographic step. The active fractions from the Superose 12 column are pooled and concentrated to a final concentration of approximately 25 μg enzyme/mL. The kinase is assayed with 1 mg/mL histone HI in the presence of 15 μM [γ-32P]ATP, during 10 minutes in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/cyclin D1 is obtained from insect cell lysates. Cdk4 is a fusion protein with glutathione-S-transferase and the active complex is purified on glutathione-agarose beads. Its kinase activity is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. After a 15-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10 % SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. p33cdk4/cyclinD 2 is obtained from insect cell lysates. It is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. After a 30-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10% SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. MAP kinase erkl (tagged with glutathione-S-transferase), is expressed in bacteria, purified on glutathione-agarose beads and assayed with 1 mg myelin basic protein/ml in the presence of 15 μM [γ-32P]ATP as described above for the p34cdc2cyclin B kinase. His-tagged erkl and erk2 are activated in vitro by mitogen-activated protein kinase kinase, purified (Ni-affinity and Mono Q) and assayed as described above during 10 minutes in a final volume of 30 μL. Protein kinase C isoforms are purified from baculovirus infected sf9 insect cells and assayed with 1 mg/mL protamine sulfate in the presence of 15 μM [γ-32P]ATP, during 10 minutes at 30 °C, in a final volume of 30 μL. Phosphorylated protamine sulfate is recovered on Whatman P81 phosphocellulose paper as described for the cdc2 kinase. The catalytic subunit of cAMP-dependent protein kinase, purified from bovine heart, is assayed with 1 mg histone Hl/ml, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. cGMP-dependent protein kinase, purified to homogeneity from bovine tracheal smooth muscle, is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. Casein kinase 2 is isolated from rat liver cytosol and assayed with 1 mg casein/mL and 15 μM [γ-32P]ATP. The substrate is spotted on Whatmann 3MM filters and washed with 10% (mass/vol.) trichloroacetic acid. Myosin light chain kinase, purified from chicken gizzard is assayed in the presence of 100 nM calmodulin, 100 μM CaCl2, 50 mM Hepes, 5 mM MgCI,, 1 mM dithiothreitol and 0.1 mg BSA/ml at pH 7.5 using a synthetic peptide based on the smooth-muscle myosin light-chain phosphorylation site and in the presence of 15 μM [γ-32P]ATP, in a final volume of 50 μL. Incorporation of radioactive phosphate is monitored on phosphocellulose filters as described above. ASK-γ, a plant homologue of GSK-3, is expressed as a glutathione-S-transferase fusion protein in Escherichia coli and purified on glutathione-agarose. ASK-γ kinase is assayed, for 10 minutes at 30 °C, with 5 μg myelin basic protein, in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. The phosphorylated myelin basic protein is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. Insulin receptor tyrosine kinase domain (CIRK-41) is overexpressed in a baculovirus system and purified to homogeneity. Its kinase activity is assayed, for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. c-src kinase is purified from infected Sf9 cells. The v-abl kinase is expressed in E. coli and affinity purified on IgG Affigel 10. Both kinases are assayed for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase.
Cell Research:[1]
- Collapse
  • Cell lines: Leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer
  • Concentrations: 0.01 - 100 μM
  • Incubation Time: 48 hours
  • Method: 60 human tumour cell lines comprising nine tumor types are cultured for 24 hours prior to a 48-hour continuous exposure to 0.01-100 μM roscovitine. A sulforhodaminine B protein assay is used to estimate the cytotoxicity.
    (Only for Reference)
Animal Research:[4]
- Collapse
  • Animal Models: A4573 cells are injected s.c. into the right posterior flank of CD1 nu/nu mice.
  • Dosages: ≤50 mg/kg
  • Administration: Administered via i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 71 mg/mL (200.31 mM)
Water Insoluble
Ethanol ''6 mg/mL
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+69% PEG 400
For best results, use promptly after mixing.
5mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 354.45
Formula

C19H26N6O

CAS No. 186692-46-6
Storage powder
in solvent
Synonyms Seliciclib, R-roscovitine
Smiles CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02649751 Terminated Drug: Roscovitine|Drug: Placebo Cystic Fibrosis University Hospital Brest|ManRos Therapeutics|Cyclacel Pharmaceuticals Inc. February 22 2016 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How can I reconstitute the drug for in vivo studies?

  • Answer:

    S1153 in 1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+PEG 400 is a clear solution which is okay for injection. And S1153 in 1% DMSO+30% polyethylene glycol+1% Tween 80 at 30mg/ml is a suspension, which is fine for oral gavage.

CDK Signaling Pathway Map

CDK Inhibitors with Unique Features

Related CDK Products

Tags: buy Roscovitine (CYC202) | Roscovitine (CYC202) supplier | purchase Roscovitine (CYC202) | Roscovitine (CYC202) cost | Roscovitine (CYC202) manufacturer | order Roscovitine (CYC202) | Roscovitine (CYC202) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID